XDR-TB Treatment Market Dynamics & Pipeline Analysis (2026–2033): Emerging Regimens, Market Drivers, and Strategic Insights
Extensively Drug-Resistant Tuberculosis (XDR-TB) presents a critical global health challenge, caused by Mycobacterium tuberculosis strains that are resistant to first-line drugs, fluoroquinolones, and at least one additional second-line injectable drug or novel agent like bedaquiline. Market Overview & Growth Drivers The global Xdr-Tb Treatment Market is expanding...
0 Comments 0 Shares 54 Views 0 Reviews